Virtual Events

Molecular Therapy Presents: Advancements in Pediatric Cancer Therapy

August 06, 2025 | 01:00 PM CT


From the first use of chemotherapy in the 1960s to the first FDA-approved CAR T-cell therapy in 2017, the treatment of pediatric cancers has evolved to become safer and more effective, increasing survival rates from 10% to nearly 80%. Despite these pivotal successes, cancer remains a leading cause of death among children and adolescents. This webinar features talks focused on cell therapy for acute myeloid leukemia and updates on rare pediatric cancer.

Moderator: Timothy Cripe, MD, PhD, Nationwide Children's Hospital

Speakers + Topics:

  • Swati Naik, MBBS, St. Jude Children's Research Hospital
    Updates on cell therapy for AML

  • Jacquelyn Crane, MD, Children's Hospital of Philadelphia
    Updates on rare pediatric cancer

2025

ASGCT Policy Summit

Sept. 25-26, 2025 | Washington, D.C.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.